Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma Article Swipe
Sven Borchmann
,
Erel Joffe
,
Craig H. Moskowitz
,
Andrew D. Zelenetz
,
Ariela Noy
,
Carol S. Portlock
,
John F. Gerecitano
,
Connie Lee Batlevi
,
Philip Caron
,
Pamela Drullinsky
,
Audrey Hamilton
,
Paul A. Hamlin
,
Steven M. Horwitz
,
Anita Kumar
,
Matthew J. Matasar
,
Alison J. Moskowitz
,
Colette Owens
,
M. Lia Palomba
,
Anas Younes
,
David J. Straus
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1182/blood-2018-10-877761
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1182/blood-2018-10-877761
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of lymphoma that, like other Hodgkin lymphomas, has historically been treated aggressively. However, in most cases, NLPHL has an indolent course, which raises the question of to what extent these patients require aggressive upfront treatment. We describe the management and outcomes of consecutive NLPHL patients diagnosed at Memorial Sloan Kettering Cancer Center (MSK), with a focus on evaluating active surveillance. All patients aged 16 years or older diagnosed and followed at MSK between 1974 and 2016 were included. Treatment outcomes were compared between management with active surveillance and other strategies. We identified 163 consecutive patients who were treated with radiotherapy alone (46%), active surveillance (23%), chemotherapy (16%), combined modality (12%), or rituximab monotherapy (4%). Median follow-up was 69 months. Five-year progression-free survival (PFS), second PFS (PFS2), and overall survival (OS) estimates were 85% (95% confidence interval [CI], 78-90), 97% (95% CI, 92-99), and 99% (95% CI, 95-100), respectively. Only 1 of 7 deaths was lymphoma related. Patients managed with active surveillance had slightly shorter PFS than those receiving any active treatment, with 5-year PFS of 77% (95% CI, 56-89) vs 87% (95% CI, 79-92; P = .017). This difference did not translate into better PFS2 or OS. Only 10 patients managed with active surveillance (27%) eventually required treatment, after a median of 61 months, and none died. NLPHL has an excellent prognosis. Within the limitations of a retrospective analysis, active surveillance is a viable initial management strategy for selected NLPHL patients.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1182/blood-2018-10-877761
- https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdf
- OA Status
- bronze
- Cited By
- 55
- References
- 34
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2911692028
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2911692028Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1182/blood-2018-10-877761Digital Object Identifier
- Title
-
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-02-15Full publication date if available
- Authors
-
Sven Borchmann, Erel Joffe, Craig H. Moskowitz, Andrew D. Zelenetz, Ariela Noy, Carol S. Portlock, John F. Gerecitano, Connie Lee Batlevi, Philip Caron, Pamela Drullinsky, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Colette Owens, M. Lia Palomba, Anas Younes, David J. StrausList of authors in order
- Landing page
-
https://doi.org/10.1182/blood-2018-10-877761Publisher landing page
- PDF URL
-
https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdfDirect OA link when available
- Concepts
-
Medicine, Internal medicine, Rituximab, Lymphoma, Confidence interval, Chemotherapy, Oncology, Radiation therapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
55Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 4, 2023: 9, 2022: 8, 2021: 12Per-year citation counts (last 5 years)
- References (count)
-
34Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2911692028 |
|---|---|
| doi | https://doi.org/10.1182/blood-2018-10-877761 |
| ids.doi | https://doi.org/10.1182/blood-2018-10-877761 |
| ids.mag | 2911692028 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30770396 |
| ids.openalex | https://openalex.org/W2911692028 |
| fwci | 7.45767205 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000293 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adolescent |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000328 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Adult |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000368 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Aged |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D019468 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Disease Management |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005260 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Female |
| mesh[6].qualifier_ui | Q000473 |
| mesh[6].descriptor_ui | D006689 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | pathology |
| mesh[6].descriptor_name | Hodgkin Disease |
| mesh[7].qualifier_ui | Q000628 |
| mesh[7].descriptor_ui | D006689 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapy |
| mesh[7].descriptor_name | Hodgkin Disease |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | Q000473 |
| mesh[9].descriptor_ui | D008214 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pathology |
| mesh[9].descriptor_name | Lymphocytes |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D008297 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Male |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008875 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Middle Aged |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000077982 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Progression-Free Survival |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D016896 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Treatment Outcome |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D057832 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Watchful Waiting |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D055815 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Young Adult |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000293 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Adolescent |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000328 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Adult |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000368 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Aged |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000818 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Animals |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D019468 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Disease Management |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D005260 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Female |
| mesh[22].qualifier_ui | Q000473 |
| mesh[22].descriptor_ui | D006689 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | pathology |
| mesh[22].descriptor_name | Hodgkin Disease |
| mesh[23].qualifier_ui | Q000628 |
| mesh[23].descriptor_ui | D006689 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | therapy |
| mesh[23].descriptor_name | Hodgkin Disease |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | Q000473 |
| mesh[25].descriptor_ui | D008214 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | pathology |
| mesh[25].descriptor_name | Lymphocytes |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008297 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Male |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008875 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Middle Aged |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000077982 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Progression-Free Survival |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D016896 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Treatment Outcome |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D057832 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Watchful Waiting |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D055815 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Young Adult |
| type | article |
| title | Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma |
| biblio.issue | 20 |
| biblio.volume | 133 |
| biblio.last_page | 2129 |
| biblio.first_page | 2121 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10685 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9975000023841858 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Viral-associated cancers and disorders |
| topics[2].id | https://openalex.org/T12212 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9925000071525574 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | CNS Lymphoma Diagnosis and Treatment |
| is_xpac | False |
| apc_list.value | 5000 |
| apc_list.currency | USD |
| apc_list.value_usd | 5000 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7844224572181702 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C126322002 |
| concepts[1].level | 1 |
| concepts[1].score | 0.639984130859375 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[1].display_name | Internal medicine |
| concepts[2].id | https://openalex.org/C2780653079 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6265538334846497 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q412323 |
| concepts[2].display_name | Rituximab |
| concepts[3].id | https://openalex.org/C2779338263 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5892167091369629 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[3].display_name | Lymphoma |
| concepts[4].id | https://openalex.org/C44249647 |
| concepts[4].level | 2 |
| concepts[4].score | 0.49492210149765015 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[4].display_name | Confidence interval |
| concepts[5].id | https://openalex.org/C2776694085 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4504642188549042 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[5].display_name | Chemotherapy |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.44681432843208313 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C509974204 |
| concepts[7].level | 2 |
| concepts[7].score | 0.430152952671051 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[7].display_name | Radiation therapy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7844224572181702 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/internal-medicine |
| keywords[1].score | 0.639984130859375 |
| keywords[1].display_name | Internal medicine |
| keywords[2].id | https://openalex.org/keywords/rituximab |
| keywords[2].score | 0.6265538334846497 |
| keywords[2].display_name | Rituximab |
| keywords[3].id | https://openalex.org/keywords/lymphoma |
| keywords[3].score | 0.5892167091369629 |
| keywords[3].display_name | Lymphoma |
| keywords[4].id | https://openalex.org/keywords/confidence-interval |
| keywords[4].score | 0.49492210149765015 |
| keywords[4].display_name | Confidence interval |
| keywords[5].id | https://openalex.org/keywords/chemotherapy |
| keywords[5].score | 0.4504642188549042 |
| keywords[5].display_name | Chemotherapy |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.44681432843208313 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/radiation-therapy |
| keywords[7].score | 0.430152952671051 |
| keywords[7].display_name | Radiation therapy |
| language | en |
| locations[0].id | doi:10.1182/blood-2018-10-877761 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S200071133 |
| locations[0].source.issn | 0006-4971, 1528-0020 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0006-4971 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Blood |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Blood |
| locations[0].landing_page_url | https://doi.org/10.1182/blood-2018-10-877761 |
| locations[1].id | pmid:30770396 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Blood |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30770396 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7022227 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Blood |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7022227 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5072973570 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6662-6864 |
| authorships[0].author.display_name | Sven Borchmann |
| authorships[0].countries | DE, US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[0].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I180923762 |
| authorships[0].affiliations[1].raw_affiliation_string | Center for Molecular Medicine, Else-Kröner Forschungskolleg Clonal Evolution in Cancer and Department I for Medicine, University of Cologne, Cologne, Germany; |
| authorships[0].institutions[0].id | https://openalex.org/I180923762 |
| authorships[0].institutions[0].ror | https://ror.org/00rcxh774 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I180923762 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | University of Cologne |
| authorships[0].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[0].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sven Borchmann |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Center for Molecular Medicine, Else-Kröner Forschungskolleg Clonal Evolution in Cancer and Department I for Medicine, University of Cologne, Cologne, Germany;, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[1].author.id | https://openalex.org/A5001663845 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7883-289X |
| authorships[1].author.display_name | Erel Joffe |
| authorships[1].countries | IL, US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800389475 |
| authorships[1].affiliations[0].raw_affiliation_string | Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel; and |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I1334819555 |
| authorships[1].affiliations[1].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[1].institutions[0].id | https://openalex.org/I2800389475 |
| authorships[1].institutions[0].ror | https://ror.org/01vjtf564 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2800389475, https://openalex.org/I64767286 |
| authorships[1].institutions[0].country_code | IL |
| authorships[1].institutions[0].display_name | Rabin Medical Center |
| authorships[1].institutions[1].id | https://openalex.org/I1334819555 |
| authorships[1].institutions[1].ror | https://ror.org/02yrq0923 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I1334819555 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Erel Joffe |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel; and, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[2].author.id | https://openalex.org/A5001102192 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9189-3152 |
| authorships[2].author.display_name | Craig H. Moskowitz |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[2].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[2].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[2].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Craig H. Moskowitz |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[3].author.id | https://openalex.org/A5061964017 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1403-6883 |
| authorships[3].author.display_name | Andrew D. Zelenetz |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[3].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[3].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[3].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Andrew D. Zelenetz |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[4].author.id | https://openalex.org/A5014543424 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3001-4898 |
| authorships[4].author.display_name | Ariela Noy |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[4].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[4].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[4].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ariela Noy |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[5].author.id | https://openalex.org/A5113686542 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Carol S. Portlock |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[5].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[5].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[5].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Carol S. Portlock |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[6].author.id | https://openalex.org/A5069721801 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9300-9287 |
| authorships[6].author.display_name | John F. Gerecitano |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[6].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[6].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[6].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | John F. Gerecitano |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[7].author.id | https://openalex.org/A5045676616 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-9036-9463 |
| authorships[7].author.display_name | Connie Lee Batlevi |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[7].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[7].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[7].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Connie L. Batlevi |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[8].author.id | https://openalex.org/A5076564214 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Philip Caron |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[8].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[8].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[8].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Philip C. Caron |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[9].author.id | https://openalex.org/A5057941582 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Pamela Drullinsky |
| authorships[9].countries | US |
| authorships[9].affiliations[0].raw_affiliation_string | Breast Medicine Service and |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I1334819555 |
| authorships[9].affiliations[1].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[9].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[9].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Pamela Drullinsky |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Breast Medicine Service and, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[10].author.id | https://openalex.org/A5013453409 |
| authorships[10].author.orcid | https://orcid.org/0009-0004-3298-3432 |
| authorships[10].author.display_name | Audrey Hamilton |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[10].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[10].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[10].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Audrey Hamilton |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[11].author.id | https://openalex.org/A5012810450 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-9500-1804 |
| authorships[11].author.display_name | Paul A. Hamlin |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[11].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[11].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[11].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Paul A. Hamlin |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[12].author.id | https://openalex.org/A5069406522 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-6399-2006 |
| authorships[12].author.display_name | Steven M. Horwitz |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[12].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[12].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[12].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Steven M. Horwitz |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[13].author.id | https://openalex.org/A5089206024 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-1381-5810 |
| authorships[13].author.display_name | Anita Kumar |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[13].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[13].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[13].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Anita Kumar |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[14].author.id | https://openalex.org/A5049461398 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4581-3721 |
| authorships[14].author.display_name | Matthew J. Matasar |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[14].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[14].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[14].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Matthew J. Matasar |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[15].author.id | https://openalex.org/A5062879857 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-3408-050X |
| authorships[15].author.display_name | Alison J. Moskowitz |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[15].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[15].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[15].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Alison J. Moskowitz |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[16].author.id | https://openalex.org/A5055986807 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Colette Owens |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[16].affiliations[0].raw_affiliation_string | Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I1334819555 |
| authorships[16].affiliations[1].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[16].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Colette N. Owens |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[17].author.id | https://openalex.org/A5052659722 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-5099-9156 |
| authorships[17].author.display_name | M. Lia Palomba |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[17].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[17].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[17].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | M. Lia Palomba |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[18].author.id | https://openalex.org/A5068152076 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0001-4133 |
| authorships[18].author.display_name | Anas Younes |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[18].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[18].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[18].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Anas Younes |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[19].author.id | https://openalex.org/A5006117950 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-8364-6816 |
| authorships[19].author.display_name | David J. Straus |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[19].affiliations[0].raw_affiliation_string | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| authorships[19].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[19].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | David J. Straus |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2411583971, https://openalex.org/W2781286807, https://openalex.org/W31297289, https://openalex.org/W2387970634, https://openalex.org/W2089609493, https://openalex.org/W2417555288, https://openalex.org/W2349204430, https://openalex.org/W3211657369, https://openalex.org/W2353276349, https://openalex.org/W2347438058 |
| cited_by_count | 55 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 9 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 8 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 12 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 12 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 7 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1182/blood-2018-10-877761 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S200071133 |
| best_oa_location.source.issn | 0006-4971, 1528-0020 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0006-4971 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Blood |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Blood |
| best_oa_location.landing_page_url | https://doi.org/10.1182/blood-2018-10-877761 |
| primary_location.id | doi:10.1182/blood-2018-10-877761 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S200071133 |
| primary_location.source.issn | 0006-4971, 1528-0020 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0006-4971 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Blood |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | https://ashpublications.org/blood/article-pdf/133/20/2121/1557220/blood877761.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Blood |
| primary_location.landing_page_url | https://doi.org/10.1182/blood-2018-10-877761 |
| publication_date | 2019-02-15 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2518731208, https://openalex.org/W2168678052, https://openalex.org/W1972497571, https://openalex.org/W2154021280, https://openalex.org/W2008432104, https://openalex.org/W2120226021, https://openalex.org/W2147657290, https://openalex.org/W2063487814, https://openalex.org/W2020521632, https://openalex.org/W2006625003, https://openalex.org/W2151558804, https://openalex.org/W1972342014, https://openalex.org/W2614289524, https://openalex.org/W2142278289, https://openalex.org/W2179852200, https://openalex.org/W1893894352, https://openalex.org/W2400126805, https://openalex.org/W2133657022, https://openalex.org/W1996801979, https://openalex.org/W2169881538, https://openalex.org/W1819862099, https://openalex.org/W2328676772, https://openalex.org/W2072351874, https://openalex.org/W2253668567, https://openalex.org/W2227484437, https://openalex.org/W2181228347, https://openalex.org/W2170684315, https://openalex.org/W2135361829, https://openalex.org/W1982790762, https://openalex.org/W2116895103, https://openalex.org/W1608269846, https://openalex.org/W2403421660, https://openalex.org/W2086951200, https://openalex.org/W2211631799 |
| referenced_works_count | 34 |
| abstract_inverted_index.1 | 159 |
| abstract_inverted_index.7 | 161 |
| abstract_inverted_index.= | 195 |
| abstract_inverted_index.P | 194 |
| abstract_inverted_index.a | 7, 64, 219, 236, 242 |
| abstract_inverted_index.10 | 208 |
| abstract_inverted_index.16 | 73 |
| abstract_inverted_index.61 | 222 |
| abstract_inverted_index.69 | 127 |
| abstract_inverted_index.We | 45, 100 |
| abstract_inverted_index.an | 28, 229 |
| abstract_inverted_index.at | 56, 80 |
| abstract_inverted_index.in | 23 |
| abstract_inverted_index.is | 6, 241 |
| abstract_inverted_index.of | 10, 35, 51, 160, 184, 221, 235 |
| abstract_inverted_index.on | 66 |
| abstract_inverted_index.or | 75, 120, 205 |
| abstract_inverted_index.to | 36 |
| abstract_inverted_index.vs | 189 |
| abstract_inverted_index.163 | 102 |
| abstract_inverted_index.77% | 185 |
| abstract_inverted_index.85% | 142 |
| abstract_inverted_index.87% | 190 |
| abstract_inverted_index.97% | 148 |
| abstract_inverted_index.99% | 153 |
| abstract_inverted_index.All | 70 |
| abstract_inverted_index.CI, | 150, 155, 187, 192 |
| abstract_inverted_index.MSK | 81 |
| abstract_inverted_index.OS. | 206 |
| abstract_inverted_index.PFS | 134, 174, 183 |
| abstract_inverted_index.and | 49, 78, 84, 97, 136, 152, 224 |
| abstract_inverted_index.any | 178 |
| abstract_inverted_index.did | 199 |
| abstract_inverted_index.for | 247 |
| abstract_inverted_index.had | 171 |
| abstract_inverted_index.has | 17, 27, 228 |
| abstract_inverted_index.not | 200 |
| abstract_inverted_index.the | 33, 47, 233 |
| abstract_inverted_index.was | 126, 163 |
| abstract_inverted_index.who | 105 |
| abstract_inverted_index.(95% | 143, 149, 154, 186, 191 |
| abstract_inverted_index.(OS) | 139 |
| abstract_inverted_index.1974 | 83 |
| abstract_inverted_index.2016 | 85 |
| abstract_inverted_index.Only | 158, 207 |
| abstract_inverted_index.PFS2 | 204 |
| abstract_inverted_index.This | 197 |
| abstract_inverted_index.aged | 72 |
| abstract_inverted_index.been | 19 |
| abstract_inverted_index.into | 202 |
| abstract_inverted_index.like | 13 |
| abstract_inverted_index.most | 24 |
| abstract_inverted_index.none | 225 |
| abstract_inverted_index.rare | 8 |
| abstract_inverted_index.than | 175 |
| abstract_inverted_index.were | 86, 90, 106, 141 |
| abstract_inverted_index.what | 37 |
| abstract_inverted_index.with | 63, 94, 108, 168, 181, 211 |
| abstract_inverted_index.(27%) | 214 |
| abstract_inverted_index.(4%). | 123 |
| abstract_inverted_index.NLPHL | 26, 53, 227, 249 |
| abstract_inverted_index.Sloan | 58 |
| abstract_inverted_index.[CI], | 146 |
| abstract_inverted_index.after | 218 |
| abstract_inverted_index.alone | 110 |
| abstract_inverted_index.died. | 226 |
| abstract_inverted_index.focus | 65 |
| abstract_inverted_index.older | 76 |
| abstract_inverted_index.other | 14, 98 |
| abstract_inverted_index.that, | 12 |
| abstract_inverted_index.these | 39 |
| abstract_inverted_index.those | 176 |
| abstract_inverted_index.which | 31 |
| abstract_inverted_index.years | 74 |
| abstract_inverted_index.(12%), | 119 |
| abstract_inverted_index.(16%), | 116 |
| abstract_inverted_index.(23%), | 114 |
| abstract_inverted_index.(46%), | 111 |
| abstract_inverted_index.(MSK), | 62 |
| abstract_inverted_index.(PFS), | 132 |
| abstract_inverted_index..017). | 196 |
| abstract_inverted_index.5-year | 182 |
| abstract_inverted_index.56-89) | 188 |
| abstract_inverted_index.79-92; | 193 |
| abstract_inverted_index.Cancer | 60 |
| abstract_inverted_index.Center | 61 |
| abstract_inverted_index.Median | 124 |
| abstract_inverted_index.Within | 232 |
| abstract_inverted_index.active | 68, 95, 112, 169, 179, 212, 239 |
| abstract_inverted_index.better | 203 |
| abstract_inverted_index.cases, | 25 |
| abstract_inverted_index.deaths | 162 |
| abstract_inverted_index.extent | 38 |
| abstract_inverted_index.median | 220 |
| abstract_inverted_index.raises | 32 |
| abstract_inverted_index.second | 133 |
| abstract_inverted_index.viable | 243 |
| abstract_inverted_index.(NLPHL) | 5 |
| abstract_inverted_index.(PFS2), | 135 |
| abstract_inverted_index.78-90), | 147 |
| abstract_inverted_index.92-99), | 151 |
| abstract_inverted_index.Hodgkin | 3, 15 |
| abstract_inverted_index.Nodular | 1 |
| abstract_inverted_index.between | 82, 92 |
| abstract_inverted_index.course, | 30 |
| abstract_inverted_index.initial | 244 |
| abstract_inverted_index.managed | 167, 210 |
| abstract_inverted_index.months, | 223 |
| abstract_inverted_index.months. | 128 |
| abstract_inverted_index.overall | 137 |
| abstract_inverted_index.require | 41 |
| abstract_inverted_index.shorter | 173 |
| abstract_inverted_index.subtype | 9 |
| abstract_inverted_index.treated | 20, 107 |
| abstract_inverted_index.upfront | 43 |
| abstract_inverted_index.95-100), | 156 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 22 |
| abstract_inverted_index.Memorial | 57 |
| abstract_inverted_index.Patients | 166 |
| abstract_inverted_index.combined | 117 |
| abstract_inverted_index.compared | 91 |
| abstract_inverted_index.describe | 46 |
| abstract_inverted_index.followed | 79 |
| abstract_inverted_index.indolent | 29 |
| abstract_inverted_index.interval | 145 |
| abstract_inverted_index.lymphoma | 4, 11, 164 |
| abstract_inverted_index.modality | 118 |
| abstract_inverted_index.outcomes | 50, 89 |
| abstract_inverted_index.patients | 40, 54, 71, 104, 209 |
| abstract_inverted_index.question | 34 |
| abstract_inverted_index.related. | 165 |
| abstract_inverted_index.required | 216 |
| abstract_inverted_index.selected | 248 |
| abstract_inverted_index.slightly | 172 |
| abstract_inverted_index.strategy | 246 |
| abstract_inverted_index.survival | 131, 138 |
| abstract_inverted_index.Five-year | 129 |
| abstract_inverted_index.Kettering | 59 |
| abstract_inverted_index.Treatment | 88 |
| abstract_inverted_index.analysis, | 238 |
| abstract_inverted_index.diagnosed | 55, 77 |
| abstract_inverted_index.estimates | 140 |
| abstract_inverted_index.excellent | 230 |
| abstract_inverted_index.follow-up | 125 |
| abstract_inverted_index.included. | 87 |
| abstract_inverted_index.patients. | 250 |
| abstract_inverted_index.receiving | 177 |
| abstract_inverted_index.rituximab | 121 |
| abstract_inverted_index.translate | 201 |
| abstract_inverted_index.aggressive | 42 |
| abstract_inverted_index.confidence | 144 |
| abstract_inverted_index.difference | 198 |
| abstract_inverted_index.evaluating | 67 |
| abstract_inverted_index.eventually | 215 |
| abstract_inverted_index.identified | 101 |
| abstract_inverted_index.lymphomas, | 16 |
| abstract_inverted_index.management | 48, 93, 245 |
| abstract_inverted_index.prognosis. | 231 |
| abstract_inverted_index.treatment, | 180, 217 |
| abstract_inverted_index.treatment. | 44 |
| abstract_inverted_index.consecutive | 52, 103 |
| abstract_inverted_index.limitations | 234 |
| abstract_inverted_index.monotherapy | 122 |
| abstract_inverted_index.strategies. | 99 |
| abstract_inverted_index.chemotherapy | 115 |
| abstract_inverted_index.historically | 18 |
| abstract_inverted_index.radiotherapy | 109 |
| abstract_inverted_index.surveillance | 96, 113, 170, 213, 240 |
| abstract_inverted_index.aggressively. | 21 |
| abstract_inverted_index.respectively. | 157 |
| abstract_inverted_index.retrospective | 237 |
| abstract_inverted_index.surveillance. | 69 |
| abstract_inverted_index.progression-free | 130 |
| abstract_inverted_index.lymphocyte-predominant | 2 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 97 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.97004927 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |